Long Whatton, United Kingdom

John Mann

This inventor holds 5 USPTO granted patents. Top assignee: Fisons Ltd.. Active years: 1978-1980.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 63(Granted Patents)


Location History:

  • Long Whatton, EN (1978)
  • Long Whatton, GB (1979 - 1980)

Company Filing History:


Years Active: 1978-1980

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of John Mann

Introduction

John Mann is a notable inventor based in Long Whatton, GB. He has made significant contributions to the field of pharmaceuticals, holding a total of 5 patents. His work focuses on innovative compounds and compositions that have potential therapeutic applications.

Latest Patents

Among his latest patents is the invention of tricyclic mono-chromone-2-carboxylic acids. This patent describes compounds of formula I, where R₃ can represent hydrogen or an alkyl group ranging from C1 to C6. Additionally, he has developed a pharmaceutical composition that includes various compounds such as 1,3-bis(2-carboxychromon-5-yloxy)propan-2-ol and several chromone-2-carboxylic acids. These compositions are designed to be used in combination with well-known medications like aspirin and indomethacin, enhancing their therapeutic efficacy.

Career Highlights

John Mann is currently associated with Fisons Ltd., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing the understanding and application of chromone derivatives in medicine.

Collaborations

Throughout his career, John has collaborated with esteemed colleagues such as Thomas S Orr and David E Hall. These partnerships have contributed to the successful development of his patented inventions.

Conclusion

John Mann's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to influence the development of new therapeutic compositions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…